Literature DB >> 15976339

Cytokeratin phenotyping does not help in distinguishing oesophageal adenocarcinoma from cancer of the gastric cardia.

M G F van Lier1, F J Bomhof, I Leendertse, M Flens, A T Balk, R J L F Loffeld.   

Abstract

BACKGROUND: It is sometimes difficult to distinguish between cardia cancer and oesophageal cancer. AIMS: To evaluate whether cytokeratin (CK) expression of the tumour can be of value in differentiating between the two tumour types.
METHODS: Consecutive patients with a malignant tumour in the oesophagus or stomach were recruited. Biopsy specimens were taken for routine haematoxylin and eosin staining. One tissue block with representative tissue was selected for immunohistochemical staining (CK7 and CK20).
RESULTS: Endoscopically located adenocarcinoma of the oesophagus was present in 84 patients (64 men, 20 women; mean age, 68 years; range, 44-91). Cancer located primarily in the gastric cardia was present in 63 patients (42 men, 21 women; mean age, 68 years; range, 42-88). The histological diagnosis was metastasis from a primary tumour outside the oesophagus or stomach in 19 patients. The patients were divided into three groups for the immunohistochemical analysis. Patients in group A had definite oesophageal cancer, group B patients had a definite carcinoma located in the gastric cardia, and group C patients had an obstructing tumour distal in the oesophagus at the level of the diaphragm, which could not be passed with the endoscope. Paraffin wax embedded material was available from 122 patients for immunostaining and CK analysis. There was no significant difference in expression or distribution of CK7 or CK20 in the three groups of patients.
CONCLUSION: CK phenotyping cannot distinguish between cancer arising from a Barrett's oesophagus and carcinoma originating in the gastric cardia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15976339      PMCID: PMC1770716          DOI: 10.1136/jcp.2004.024265

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  18 in total

1.  Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach.

Authors:  A H Ormsby; J R Goldblum; T W Rice; J E Richter; G W Falk; M F Vaezi; T L Gramlich
Journal:  Hum Pathol       Date:  1999-03       Impact factor: 3.466

2.  Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus.

Authors:  Steven R DeMeester; Kumari S Wickramasinghe; Reginald V N Lord; Adam Friedman; Nagammapudur S Balaji; Parakrama T Chandrasoma; Jeffrey A Hagen; Jeffrey H Peters; Tom R DeMeester
Journal:  Am J Gastroenterol       Date:  2002-10       Impact factor: 10.864

3.  The yield of UGIE: a study of a ten-year period in the 'Zaanstreek'.

Authors:  R J L F Loffeld; A B M M van der Putten
Journal:  Neth J Med       Date:  2003-01       Impact factor: 1.422

4.  Continuing climb in rates of esophageal adenocarcinoma: an update.

Authors:  W J Blot; S S Devesa; J F Fraumeni
Journal:  JAMA       Date:  1993-09-15       Impact factor: 56.272

5.  Cytokeratin expression patterns in noncardia, intestinal metaplasia-associated gastric adenocarcinoma: implication for the evaluation of intestinal metaplasia and tumors at the esophagogastric junction.

Authors:  Bo Shen; Adrian H Ormsby; Chen Shen; John A Dumot; Yun-Wei Shao; Charles L Bevins; Terry L Gramlich
Journal:  Cancer       Date:  2002-02-01       Impact factor: 6.860

6.  Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach.

Authors:  U Flucke; E Steinborn; V Dries; S P Mönig; P M Schneider; J Thiele; A H Hölscher; H P Dienes; S E Baldus
Journal:  Histopathology       Date:  2003-08       Impact factor: 5.087

7.  Cytokeratin 7/20 and mucin expression patterns in oesophageal, cardia and distal gastric adenocarcinomas.

Authors:  C Gulmann; I Counihan; A Grace; S Patchett; E Leen; M Leader; E Kay
Journal:  Histopathology       Date:  2003-11       Impact factor: 5.087

8.  Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative study of adenocarcinomas of the distal esophagus and of the proximal stomach.

Authors:  Philippe Taniere; Giovanna Borghi-Scoazec; Jean-Christophe Saurin; Catherine Lombard-Bohas; Jean Boulez; Françoise Berger; Pierre Hainaut; Jean-Yves Scoazec
Journal:  Am J Surg Pathol       Date:  2002-09       Impact factor: 6.394

9.  Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden.

Authors:  L E Hansson; P Sparén; O Nyrén
Journal:  Int J Cancer       Date:  1993-05-28       Impact factor: 7.396

10.  The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?

Authors:  Ozlem Kurtkaya-Yapicier; Rasim Gencosmanoglu; Erol Avsar; Nadi Bakirci; Nurdan Tozun; Aydin Sav
Journal:  BMC Clin Pathol       Date:  2003-12-02
View more
  1 in total

1.  Immunohistochemical panel for distinguishing esophageal adenocarcinoma from squamous cell carcinoma: a combination of p63, cytokeratin 5/6, MUC5AC, and anterior gradient homolog 2 allows optimal subtyping.

Authors:  Michael A DiMaio; Shirley Kwok; Kelli D Montgomery; Anson W Lowe; Reetesh K Pai
Journal:  Hum Pathol       Date:  2012-06-28       Impact factor: 3.466

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.